Hälsosam livsstil tycks minska risken för cancer: Nytt stöd för hypotesen att övervikt och högt blodsocker ökar cancerrisken

Lakartidningen

Volumn 104, Issue 51-52, 2007, Pages 3867-3870

  Stocks, Tanja ^a   Lindahl, Bernt ^a   Stattin, P A R ^b  

^a Urologi Och Andrologi ^*

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST TUMOR; COLORECTAL TUMOR; DEVELOPED COUNTRY; DEVELOPING COUNTRY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH; HUMAN; INCIDENCE; INSULIN RESISTANCE; LIFESTYLE; MALE; METABOLIC SYNDROME X; MIGRATION; NEOPLASM; OBESITY; PROSTATE TUMOR; RISK FACTOR; SWEDEN;

ADULT; BLOOD GLUCOSE; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; EMIGRANTS AND IMMIGRANTS; FEMALE; HUMANS; INCIDENCE; INSULIN RESISTANCE; LIFE STYLE; MALE; METABOLIC SYNDROME X; NEOPLASMS; OBESITY; OVERWEIGHT; PROSTATIC NEOPLASMS; RISK FACTORS; SWEDEN; WORLD HEALTH;

EID: 38149060022     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hartemink N, Boshuizen HC, Nagelkerke NJ, Jacobs MA, van Houwelingen HC. Combining risk estimates from observational studies with different exposure cutpoints: a meta-analysis on body mass index and diabetes type 2. Am J Epidemiol. 2006;163(11):1042-52.
2. Nilsson PM, Nilsson JA, Berglund G. Population-attributable risk of coronary heart disease risk factors during long-term follow-up: the Malmo Preventive Project. J Intern Med. 2006;260(2):134-41.
3. Eliasson M, Lindahl B, Lundberg V, Stegmayr B. Diabetes and obesity in Northern Sweden: occurrence and risk factors for stroke and myocardial infarction. Scand J Public Health Suppl. 2003;61:70-7.
4. Ferlay J, Bray P, Pisani P, Parkin DM. GLOBOCAN 2002: cancer incidence. Mortality and prevalence worldwide. IARC cancer base no. 5, version 2.0. Lyon (France): IARC Press; 2004.
5. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108.
6. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579-91.
7. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625-38.
8. Strickler HD, Wylie-Rosett J, Rohan T, Hoover DR, Smoller S, Burk RD, et al. The relation of type 2 diabetes and cancer. Diabetes Technol Ther. 2001;3(2):263-74.
9. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 2005;293 (2):194-202.
10. Stattin P, Bjor O, Ferrari P, Lukanova A, Lenner P, Lindahl B, et al. Prospective study of hyperglycemia and cancer risk. Diabetes Care. 2007;30(3):561-7.
11. Rapp K, Schroeder J, Klenk J, Ulmer H, Concin H, Diem G, et al. Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia. 2006;49(5):945-52.
12. Lukanova A, Bjor O, Kaaks R, Lenner P, Lindahl B, Hallmans G, et al. Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort. Int J Cancer. 2006;118(2):458-66.
13. Bonovas S, Filioussi K, Tsantes A. Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia. 2004;47(6):1071-8.
14. Stocks T, Lukanova A, Rinaldi S, Biessy C, Dossus L, Lindahl B, et al. Insulin resistance is inversely related to prostate cancer: A prospective study in Northern Sweden. Int J Cancer. 2007;120(12):2678-86.
15. MacInnis RJ, English DR. Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control. 2006;17(8):989-1003.
16. Amling CL, Riffenburgh RH, Sun L, Moul JW, Lance RS, Kusuda L, et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol. 2004;22(3):439-45.
17. Stocks T, Lukanova A, Johansson M, Rinaldi S, Palmqvist R, Hallmans G, et al. Components of the metabolic syndrome and colorectal cancer risk; a prospective study. Int J Obes (Lond). Epub 2007 Sep 18.
18. Cowey S, Hardy RW. The metabolic syndrome: A high-risk state for cancer? Am J Pathol. 2006;169(5):1505-22.
19. Somasundar P, McFadden DW, Hileman SM, Vona-Davis L. Leptin is a growth factor in cancer. J Surg Res. 2004;116(2):337-49.
20. Glasgow RE, Lichtenstein E, Marcus AC. Why don't we see more translation of health promotion research to practice? Rethinking the efficacy-to- effectiveness transition. Am J Public Health. 2003;93(8):1261-7.